vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and WOLVERINE WORLD WIDE INC (WWW). Click either name above to swap in a different company.
WOLVERINE WORLD WIDE INC is the larger business by last-quarter revenue ($517.5M vs $493.8M, roughly 1.0× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 6.1%, a 0.7% gap on every dollar of revenue. On growth, WOLVERINE WORLD WIDE INC posted the faster year-over-year revenue change (25.5% vs -1.7%). Over the past eight quarters, WOLVERINE WORLD WIDE INC's revenue compounded faster (14.5% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Wolverine World Wide is a global designer, manufacturer and marketer of branded footwear, apparel and accessories. It owns popular brands including Merrell, Sperry, Saucony and Hush Puppies, serving outdoor, casual, workwear and athletic segments via e-commerce, retail stores and global wholesale networks.
MD vs WWW — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $517.5M |
| Net Profit | $33.7M | $31.8M |
| Gross Margin | — | 47.3% |
| Operating Margin | 9.9% | 9.7% |
| Net Margin | 6.8% | 6.1% |
| Revenue YoY | -1.7% | 25.5% |
| Net Profit YoY | 10.5% | 162.8% |
| EPS (diluted) | $0.40 | $0.37 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $517.5M | ||
| Q4 25 | $493.8M | — | ||
| Q3 25 | $492.9M | $470.3M | ||
| Q2 25 | $468.8M | $474.2M | ||
| Q1 25 | $458.4M | $412.3M | ||
| Q4 24 | $502.4M | $494.7M | ||
| Q3 24 | $511.2M | $440.2M | ||
| Q2 24 | $504.3M | $425.2M |
| Q1 26 | — | $31.8M | ||
| Q4 25 | $33.7M | — | ||
| Q3 25 | $71.7M | $25.1M | ||
| Q2 25 | $39.3M | $26.8M | ||
| Q1 25 | $20.7M | $12.1M | ||
| Q4 24 | $30.5M | $23.1M | ||
| Q3 24 | $19.4M | $23.2M | ||
| Q2 24 | $-153.0M | $13.8M |
| Q1 26 | — | 47.3% | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 47.5% | ||
| Q2 25 | — | 47.2% | ||
| Q1 25 | — | 47.2% | ||
| Q4 24 | — | 43.4% | ||
| Q3 24 | — | 45.1% | ||
| Q2 24 | — | 43.1% |
| Q1 26 | — | 9.7% | ||
| Q4 25 | 9.9% | — | ||
| Q3 25 | 13.8% | 8.4% | ||
| Q2 25 | 12.8% | 8.6% | ||
| Q1 25 | 7.0% | 4.8% | ||
| Q4 24 | 7.8% | 7.4% | ||
| Q3 24 | 6.6% | 7.9% | ||
| Q2 24 | -31.3% | 6.8% |
| Q1 26 | — | 6.1% | ||
| Q4 25 | 6.8% | — | ||
| Q3 25 | 14.5% | 5.3% | ||
| Q2 25 | 8.4% | 5.7% | ||
| Q1 25 | 4.5% | 2.9% | ||
| Q4 24 | 6.1% | 4.7% | ||
| Q3 24 | 3.8% | 5.3% | ||
| Q2 24 | -30.3% | 3.2% |
| Q1 26 | — | $0.37 | ||
| Q4 25 | $0.40 | — | ||
| Q3 25 | $0.84 | $0.30 | ||
| Q2 25 | $0.46 | $0.32 | ||
| Q1 25 | $0.24 | $0.15 | ||
| Q4 24 | $0.37 | $0.29 | ||
| Q3 24 | $0.23 | $0.28 | ||
| Q2 24 | $-1.84 | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | — |
| Total DebtLower is stronger | $570.5M | $621.7M |
| Stockholders' EquityBook value | $865.9M | $408.0M |
| Total Assets | $2.2B | $1.7B |
| Debt / EquityLower = less leverage | 0.66× | 1.52× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $375.2M | — | ||
| Q3 25 | $340.1M | — | ||
| Q2 25 | $224.7M | — | ||
| Q1 25 | $99.0M | — | ||
| Q4 24 | $229.9M | — | ||
| Q3 24 | $103.8M | — | ||
| Q2 24 | $19.4M | — |
| Q1 26 | — | $621.7M | ||
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | $676.4M | ||
| Q2 25 | $583.9M | $708.5M | ||
| Q1 25 | $590.5M | $710.8M | ||
| Q4 24 | $597.1M | $648.0M | ||
| Q3 24 | — | $702.8M | ||
| Q2 24 | — | $814.7M |
| Q1 26 | — | $408.0M | ||
| Q4 25 | $865.9M | — | ||
| Q3 25 | $890.7M | $376.7M | ||
| Q2 25 | $833.8M | $344.0M | ||
| Q1 25 | $789.2M | $310.6M | ||
| Q4 24 | $764.9M | $312.9M | ||
| Q3 24 | $732.5M | $295.2M | ||
| Q2 24 | $706.5M | $262.1M |
| Q1 26 | — | $1.7B | ||
| Q4 25 | $2.2B | — | ||
| Q3 25 | $2.2B | $1.7B | ||
| Q2 25 | $2.1B | $1.8B | ||
| Q1 25 | $2.0B | $1.7B | ||
| Q4 24 | $2.2B | $1.7B | ||
| Q3 24 | $2.1B | $1.8B | ||
| Q2 24 | $2.0B | $1.8B |
| Q1 26 | — | 1.52× | ||
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | 1.80× | ||
| Q2 25 | 0.70× | 2.06× | ||
| Q1 25 | 0.75× | 2.29× | ||
| Q4 24 | 0.78× | 2.07× | ||
| Q3 24 | — | 2.38× | ||
| Q2 24 | — | 3.11× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $146.2M |
| Free Cash FlowOCF − Capex | — | $145.6M |
| FCF MarginFCF / Revenue | — | 28.1% |
| Capex IntensityCapex / Revenue | — | 0.1% |
| Cash ConversionOCF / Net Profit | 3.39× | 4.60× |
| TTM Free Cash FlowTrailing 4 quarters | — | $125.5M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $146.2M | ||
| Q4 25 | $114.1M | — | ||
| Q3 25 | $137.3M | $33.0M | ||
| Q2 25 | $137.2M | $44.6M | ||
| Q1 25 | $-117.5M | $-83.8M | ||
| Q4 24 | $133.0M | $82.4M | ||
| Q3 24 | $91.8M | $108.2M | ||
| Q2 24 | $107.0M | $26.7M |
| Q1 26 | — | $145.6M | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $30.1M | ||
| Q2 25 | — | $41.2M | ||
| Q1 25 | — | $-91.4M | ||
| Q4 24 | — | $74.4M | ||
| Q3 24 | — | $104.1M | ||
| Q2 24 | — | $23.7M |
| Q1 26 | — | 28.1% | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 6.4% | ||
| Q2 25 | — | 8.7% | ||
| Q1 25 | — | -22.2% | ||
| Q4 24 | — | 15.0% | ||
| Q3 24 | — | 23.6% | ||
| Q2 24 | — | 5.6% |
| Q1 26 | — | 0.1% | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 0.6% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 1.8% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 0.9% | ||
| Q2 24 | — | 0.7% |
| Q1 26 | — | 4.60× | ||
| Q4 25 | 3.39× | — | ||
| Q3 25 | 1.91× | 1.31× | ||
| Q2 25 | 3.49× | 1.66× | ||
| Q1 25 | -5.66× | -6.93× | ||
| Q4 24 | 4.36× | 3.57× | ||
| Q3 24 | 4.72× | 4.66× | ||
| Q2 24 | — | 1.93× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
WWW
| Sales Channel Through Intermediary | $230.2M | 44% |
| Sales Channel Directly To Consumer | $142.6M | 28% |
| Work Group | $134.0M | 26% |
| Other | $10.7M | 2% |
